Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y Xiang
Observed name:
Y. Xiang
Institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Peking Union Medical College Hospital
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Peking Union Medical College Hospital
OpenAlex ID:
A5130392971
34P Pembrolizumab (pembro) or placebo (pbo) + concurrent chemoradiotherapy (CCRT) for high-risk, locally advanced cervical cancer (LACC): Final analysis (FA) results from ENGOT-cx11/GOG-3047/KEYNOTE-A18 in participants (pts) enrolled in East Asia
2026
·
Y. Xiang
, K. Hasegawa
, et al.
·
ESMO Open
PDF
[Risk assessment of subsequent drug resistance in patients with chemoresistant gestational trophoblastic neoplasia].
2026
·
M Y Mao
, F Jiang
, et al.
·
PubMed
Show more works
View as search
Works count:
2
Citation count:
H-index:
I10-index:
Year
Topic
Type